ProMIS Neurosciences, Inc. (PMN)
9.035
+0.94
(+11.68%)
USD |
NASDAQ |
Oct 21, 16:00
9.035
0.00 (0.00%)
After-Hours: 18:10
ProMIS Neurosciences Price : 9.035 for Oct. 21, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 8.34 | 8.65 | 8.06 | 8.09 | 30254.00 |
| Oct 19, 2026 | 8.36 | 8.385 | 8.06 | 8.23 | 11343.00 |
| Oct 16, 2026 | 8.89 | 9.64 | 7.935 | 8.15 | 20418.00 |
| Oct 15, 2026 | 8.29 | 8.87 | 8.00 | 8.70 | 33544.00 |
| Oct 14, 2026 | 8.41 | 8.81 | 8.16 | 8.285 | 23376.00 |
| Oct 13, 2026 | 9.38 | 9.47 | 8.51 | 8.66 | 27131.00 |
| Oct 12, 2026 | 9.61 | 9.78 | 9.20 | 9.45 | 23725.00 |
| Oct 09, 2026 | 9.06 | 10.15 | 9.06 | 9.61 | 18853.00 |
| Oct 08, 2026 | 9.02 | 9.369 | 8.78 | 9.15 | 35275.00 |
| Oct 07, 2026 | 9.17 | 9.520 | 9.01 | 9.12 | 25166.00 |
| Oct 06, 2026 | 9.46 | 9.516 | 8.775 | 9.21 | 26459.00 |
| Oct 05, 2026 | 9.50 | 9.77 | 9.07 | 9.37 | 38205.00 |
| Oct 02, 2026 | 9.44 | 10.38 | 9.16 | 9.40 | 27805.00 |
| Oct 01, 2026 | 10.98 | 10.98 | 9.21 | 9.38 | 102139.0 |
| Sep 30, 2026 | 10.68 | 11.32 | 10.42 | 10.85 | 12684.00 |
| Sep 29, 2026 | 10.56 | 11.10 | 10.52 | 10.64 | 16935.00 |
| Sep 28, 2026 | 11.15 | 11.57 | 10.51 | 10.65 | 25057.00 |
| Sep 25, 2026 | 12.06 | 12.06 | 11.15 | 11.27 | 20104.00 |
| Sep 24, 2026 | 12.83 | 13.06 | 11.29 | 11.57 | 52696.00 |
| Sep 23, 2026 | 13.45 | 13.78 | 12.94 | 12.94 | 43687.00 |
| Sep 22, 2026 | 13.80 | 14.22 | 13.45 | 13.58 | 94202.00 |
| Sep 21, 2026 | 13.54 | 14.22 | 13.13 | 13.63 | 26238.00 |
| Sep 18, 2026 | 13.52 | 14.21 | 13.52 | 14.01 | 24466.00 |
| Sep 17, 2026 | 13.00 | 13.70 | 12.88 | 13.46 | 22781.00 |
| Sep 16, 2026 | 13.25 | 13.25 | 12.40 | 12.88 | 33289.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Edesa Biotech, Inc. | 2.74 |
| Arrowhead Pharmaceuticals, Inc. | 58.83 |
| Oncolytics Biotech, Inc. | 0.5142 |
| Sangamo Therapeutics, Inc. | 0.11 |
| Sarepta Therapeutics, Inc. | 18.57 |
Price Related Metrics
| PEG Ratio | -0.0082 |
| Price to Book Value | 1.640 |
| Earnings Yield | -148.7% |
| Market Cap | 81.02M |
| PEGY Ratio | -0.0082 |